QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 151 filers reported holding QIAGEN NV in Q3 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $156,368,000 | +7.8% | 5,580,590 | +5.5% | 0.03% | -3.3% |
Q3 2016 | $145,100,000 | +31.1% | 5,287,896 | +4.2% | 0.03% | +25.0% |
Q2 2016 | $110,689,000 | -2.1% | 5,075,155 | +0.2% | 0.02% | -7.7% |
Q1 2016 | $113,105,000 | -13.8% | 5,062,893 | +6.7% | 0.03% | -13.3% |
Q4 2015 | $131,171,000 | -0.0% | 4,743,988 | -6.7% | 0.03% | -11.8% |
Q3 2015 | $131,180,000 | +10.9% | 5,084,487 | +6.5% | 0.03% | +21.4% |
Q2 2015 | $118,299,000 | -0.4% | 4,772,040 | +1.2% | 0.03% | 0.0% |
Q1 2015 | $118,795,000 | +11.8% | 4,714,086 | +4.1% | 0.03% | +7.7% |
Q4 2014 | $106,219,000 | +3.4% | 4,527,683 | +0.4% | 0.03% | -10.3% |
Q3 2014 | $102,719,000 | -4.5% | 4,511,152 | +2.5% | 0.03% | -3.3% |
Q2 2014 | $107,579,000 | +15.2% | 4,399,963 | -0.7% | 0.03% | +7.1% |
Q1 2014 | $93,422,000 | -7.8% | 4,429,698 | +4.1% | 0.03% | -9.7% |
Q4 2013 | $101,333,000 | +15.4% | 4,255,883 | +3.7% | 0.03% | +3.3% |
Q3 2013 | $87,805,000 | +19.7% | 4,103,016 | +11.4% | 0.03% | +11.1% |
Q2 2013 | $73,330,000 | – | 3,683,058 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcah Management LLC | 248,425 | $5,915,000 | 6.83% |
Hardman Johnston Global Advisors LLC | 3,500,284 | $83,342,000 | 5.47% |
Douglas C. Lane & Associates, Inc. | 1,892,425 | $45,059,000 | 1.50% |
HARDING LOEVNER LP | 6,997,851 | $166,619,000 | 1.29% |
CREDIT AGRICOLE S A | 7,703,028 | $183,409,000 | 0.76% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $42,407,000 | 0.73% |
MANNING & NAPIER ADVISORS LLC | 6,290,930 | $149,784,000 | 0.68% |
Orbimed Advisors | 1,927,000 | $45,882,000 | 0.67% |
FIRST NEW YORK SECURITIES LLC /NY | 45,540 | $1,084,000 | 0.66% |
PRIMECAP MANAGEMENT CO/CA/ | 19,385,944 | $461,579,000 | 0.56% |